Better understanding of blood vessel constrictor needed to harness its power for patients
1's power to constrict blood vessels and help patients manage high blood pressure or heart failure, scientists must learn more about how endothelin functions naturally and in disease states, says a Medical College of Georgia researcher. Despite strong laboratory evidence that blocking endothelin-1 receptors would be an effective, targeted therapy for these two major health problems, the drugs failed patients, says Dr. Adviye Ergul, physiologist in the MCG Schools of Medicine and Graduate Studies.
"These endothelin-1 receptors are logical targets for drugs to treat hypertension because of their key role in vasoconstriction, but the targets are moving and we don't know how one target plays off another," says Dr. Ergul, who discussed novel aspects of endothelin receptor interaction during the 62nd High Blood Pressure Research Conference and Workshop in Atlanta.
"The current thinking in pharmacology is one hormone, one receptor equals boom: the effect. I think cells are much smarter," she says. This week, Dr. Ergul challenged colleagues across the country to consider emerging evidence that usual receptor communication is likely more complex than they thought and that disease may significantly alter communication.
Endothelin-1 receptors are known to interact: one way blood vessels keep a healthy tone, for example, is that a and b receptors on smooth muscle cells prompt constriction while b receptors on the lining of blood vessels work with nitric oxide to promote relaxation. Endothelin-1 receptors on the kidneys are a player as well, helping wring out excess water and salt. "There is a delicate balance," says Dr. Ergul.
But there's apparently more to the relationships. She holds up a handful of recent journal articles which reflect mounting evidence that receptors actively work as teams of two or more. That teamwork could change their function. New technology enables scientists to literally watch receptors move closer together on a cell surface, clearly indicating that something is going on.
"Numerous drugs have been developed that are antagonists that can block these receptors with the idea they can be used in hypertension and heart failure. In animal models, they worked well," she says. But in clinical trials they failed badly; a drug for heart failure actually worsened problems such as labored breathing and swelling in patients already having difficulty moving blood through their body.
The first antagonists blocked both known receptors: a and b; the next generation blocked one or the other but still didn't work. A notable exception is endothelin-1 antagonists that reduce excessive pressure and tissue buildup inside the blood vessels of patients with pulmonary hypertension. In addition to constricting blood vessels, endothelin-1 can help blood vessels grow bigger but too much can result in protein deposits that stiffen blood vessel walls.
Scientists have been scratching their heads over why blocking these receptors hasn't panned out; they've even looked for an "atypical" receptor that might explain it. But Dr. Ergul, an expert on endothelin-1's role in diabetes, believes the unexpected results are better explained by poorly understood relationships in normal and disease states. "How receptors dimerize, how they get closer together on the cell surface, likely needs to affect our drug design," she says.
Source: Medical College of Georgia
- Key player identified in cascade that leads to hypertension-related kidney damageThu, 5 Nov 2009, 12:16:11 EST
- International conference on endothelinThu, 10 Sep 2009, 13:58:48 EDT
- Double duty: Loss of protective heart failure protein causes high blood pressureMon, 5 May 2008, 15:49:57 EDT
- Cocoa flavanols improve vascular and blood pressure measures for coronary artery disease patientsTue, 6 Jul 2010, 9:30:10 EDT
- Chymase inhibitors could enhance treatment for damaged heartsThu, 25 Mar 2010, 13:34:18 EDT
Articles on the same topic
- Protein identified that plays role in blood flowThu, 18 Sep 2008, 11:00:54 EDT
- Protein identified that plays role in blood flowfrom Science CentricThu, 18 Sep 2008, 19:00:14 EDT
- Better understanding of blood vessel constrictor needed to harness its power for patientsfrom Science CentricThu, 18 Sep 2008, 18:28:32 EDT
- Better Understanding Of Blood Vessel Constrictor Needed To Harness Its Power For Patientsfrom Science DailyThu, 18 Sep 2008, 12:56:18 EDT
- Protein identified that plays role in blood flowfrom Biology News NetThu, 18 Sep 2008, 12:21:29 EDT
- Protein Identified That Plays Role In Blood Flowfrom Science DailyThu, 18 Sep 2008, 11:28:14 EDT
- Protein identified that plays role in blood flowfrom PhysorgThu, 18 Sep 2008, 11:14:27 EDT
- A Step Closer To Understanding The Cause Of High Blood Pressurefrom Scientific BloggingThu, 18 Sep 2008, 11:00:18 EDT
- Better understanding of blood vessel constrictor needed to harness its power for patientsfrom PhysorgThu, 18 Sep 2008, 10:49:05 EDT
Latest Science NewsletterGet the latest and most popular science news articles of the week in your Inbox! It's free!
Learn more about
Check out our next project, Biology.Net
From other science news sites
Popular science news articles
- Even with defects, graphene is strongest material in the world
- Detection of the cosmic gamma ray horizon: Measures all the light in the universe since the Big Bang
- Genetic engineering alters mosquitoes' sense of smell
- Allosaurus fed more like a falcon than a crocodile, new study finds
- 'Popcorn' particle pathways promise better lithium-ion batteries